Form 8-K · Current report
Veeva Systems 8-K, filed Nov 6, 2026
- Filed
- CIK
- 0001393052
- Accession no.
- 0001393052-26-000039
Summary
At Veeva Systems' 2026 Investor Day on November 5, 2026, Chief Financial Officer Brian Van Wagener said the company expects third-quarter fiscal 2027 results to meet or exceed the guidance it issued on August 26, 2026.
Key points
- Veeva's previously issued Q3 FY2027 guidance is total revenue of $932–935 million, subscription revenue of ~$782 million, services revenue of $150–153 million, non-GAAP operating income of $417–420 million, and non-GAAP fully diluted net income per share of $2.33–2.34.
- The guidance was issued on August 26, 2026 and assumed foreign exchange rates stayed near then-current levels, reflecting an immaterial impact to total revenue and non-GAAP operating income versus Q3 FY2026.
- Veeva said it could not provide GAAP targets for the quarter ended October 31, 2026 because certain excluded items, such as stock-based compensation expense, could not be reasonably predicted.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. As previously announced, on November 5, 2026, Veeva Systems Inc. (the “Company”) presented its 2026 Investor Day, which was accessible via live webcast through (and a replay of the presentation is currently available on) the Company’s investor relations website. On August 26, 2026, in its quarterly earnings conference call, the Company had previously provided preliminary guidance for certain of the Company’s anticipated financial metrics for the third quarter of fiscal year 2027. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.